X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (107) 107
female (87) 87
oncology (72) 72
index medicus (65) 65
cancer (47) 47
adult (39) 39
middle aged (38) 38
aged (35) 35
ovarian cancer (35) 35
prognosis (33) 33
ovarian neoplasms - genetics (29) 29
ovarian neoplasms - pathology (28) 28
carcinoma (26) 26
expression (26) 26
obstetrics & gynecology (25) 25
chemotherapy (23) 23
surgery (22) 22
survival (22) 22
analysis (21) 21
gene expression (20) 20
immunohistochemistry (17) 17
tumors (17) 17
male (16) 16
mutation (16) 16
neoplasm staging (15) 15
adenocarcinoma (14) 14
aged, 80 and over (14) 14
obstetrics and gynecology (14) 14
tumor cells, cultured (14) 14
ovarian neoplasms - drug therapy (13) 13
animals (12) 12
cell line, tumor (12) 12
gene expression profiling (12) 12
genes (12) 12
gynecology (12) 12
ovarian neoplasms - metabolism (12) 12
pregnancy (12) 12
retrospective studies (12) 12
endometriosis (11) 11
internal medicine (11) 11
ovarian neoplasms - mortality (11) 11
genetic aspects (10) 10
medicine & public health (10) 10
mice (10) 10
obstetrics (10) 10
paclitaxel (10) 10
patients (10) 10
polymerase chain reaction (10) 10
proteins (10) 10
care and treatment (9) 9
cisplatin (9) 9
gene expression regulation, neoplastic (9) 9
genomes (9) 9
health aspects (9) 9
medicine (9) 9
research (9) 9
research article (9) 9
reverse transcriptase polymerase chain reaction (9) 9
survival analysis (9) 9
survival rate (9) 9
therapy (9) 9
base sequence (8) 8
cell biology (8) 8
cystadenocarcinoma, serous - pathology (8) 8
diagnosis (8) 8
genes, tumor suppressor (8) 8
identification (8) 8
metastasis (8) 8
multidisciplinary sciences (8) 8
p53 (8) 8
poor-prognosis (8) 8
tumor-suppressor gene (8) 8
adenocarcinoma, clear cell - pathology (7) 7
amplification (7) 7
antineoplastic agents - pharmacology (7) 7
biochemistry & molecular biology (7) 7
biomarkers, tumor - metabolism (7) 7
cells (7) 7
follow-up studies (7) 7
molecular sequence data (7) 7
ovarian carcinoma (7) 7
ovarian neoplasms (7) 7
ovarian neoplasms - therapy (7) 7
pathology (7) 7
risk factors (7) 7
treatment outcome (7) 7
adenocarcinoma, clear cell - genetics (6) 6
apoptosis (6) 6
arid1a (6) 6
cancer research (6) 6
cancer therapies (6) 6
development and progression (6) 6
drug resistance (6) 6
drug resistance, neoplasm - genetics (6) 6
growth (6) 6
medical colleges (6) 6
medical prognosis (6) 6
mice, nude (6) 6
mutations (6) 6
original (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Placenta, ISSN 0143-4004, 09/2019, Volume 84, pp. 2 - 3
Journal Article
Placenta, ISSN 0143-4004, 09/2019, Volume 84, pp. 2 - 3
Journal Article
Placenta, 09/2019, Volume 84, p. 2
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2019, Volume 37, Issue 27, pp. 2406 - 2415
Journal Article
Nature, ISSN 0028-0836, 02/2010, Volume 463, Issue 7283, pp. 899 - 905
Journal Article
Nature Genetics, ISSN 1061-4036, 06/2017, Volume 49, Issue 6, pp. 856 - 864
Journal Article
European Journal of Cancer, ISSN 0959-8049, 06/2017, Volume 78, p. 133
Despite the support for including patient-reported outcomes (PROs) and health-related quality of life in clinical trials, there have been deficiencies in how... 
Medical research | Conferences | Ovarian carcinoma | Gynecology | Clinical trials | Patients | Survival | Clinical outcomes | Ovarian cancer | Quality of life | Missing data | Chemotherapy | Platinum | Cancer
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2005, Volume 11, Issue 16, pp. 6030 - 6039
Journal Article
Journal Article
Placenta, ISSN 0143-4004, 08/2019, Volume 83, pp. e55 - e55
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2009, Volume 15, Issue 4, pp. 1417 - 1427
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 05/2016, Volume 55, Issue 5, pp. 832 - 841
Among epithelial ovarian cancers, clear cell carcinoma of the ovary (CCC) has unique clinical and molecular characteristics that include chemoresistance... 
Stat3 | tocilizumab | IL‐6R | clear cell carcinoma of the ovary | IL‐6 | IL-6R | Tocilizumab | Clear cell carcinoma of the ovary | IL-6 | TARGETED THERAPY | PROGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIBODY | CYTOKINE | PROLIFERATION | CANCER | SIGNATURE | ONCOLOGY | GROWTH | SILTUXIMAB | EXPRESSION | Cell Survival - drug effects | Prognosis | Interleukin-6 - genetics | Adenocarcinoma, Clear Cell - metabolism | Receptors, Interleukin-6 - genetics | Humans | Ovarian Neoplasms - pathology | Ovarian Neoplasms - genetics | Cell Movement - drug effects | Signal Transduction - drug effects | Antibodies, Monoclonal, Humanized - pharmacology | Cell Line, Tumor | Female | Adenocarcinoma, Clear Cell - pathology | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Ovarian Neoplasms - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Adenocarcinoma, Clear Cell - genetics | Interleukin-6 - metabolism | STAT3 Transcription Factor - metabolism | Receptors, Interleukin-6 - metabolism | Chemotherapy | Cytokines | Drug resistance | Tumors | Ovarian cancer | Transcription | Interleukin | Stat3 protein | Chemoresistance | Cytotoxicity | siRNA | Kinases | Carcinogenesis | Anticancer properties | Interleukin 6 | Signal transduction | Carcinogens | Ribonucleic acids | Medical prognosis | Surgery | Antitumor activity | Inhibition | Index Medicus
Journal Article